According to research conducted by Future Market Insights, the global Viral RNA Extraction Kit Market is expected to witness significant growth during the projected period, with a compound annual growth rate (CAGR) of 7.2%. Following a valuation of USD 200.6 million at the end of 2022, the market is projected to increase to USD 210.8 million in 2023 and reach USD 421.4 million by 2033. This growth trajectory reflects the market’s strong performance and increasing demand across various sectors.
Key Growth Drivers
Several factors are contributing to the anticipated expansion of the global market:
- Increasing Demand Across Industries: A broad range of industries is driving demand, resulting in robust market growth as businesses seek innovative solutions to enhance efficiency and performance.
- Technological Advancements: Continuous innovations and advancements in technology are enabling businesses to optimize their operations and improve product offerings, further fueling market growth.
- Growing Consumer Awareness: As consumers become more aware of the benefits associated with various products and services, the demand for high-quality offerings is increasing.
The process of RNA extraction, also known as RNA isolation, involves the separation of RNA from a cell. The utilization of this technique is advantageous in various applications such as gene expression analysis, pathogen identification, and classification. Due to its reliance on nucleic acid detection, this technique exhibits high levels of accuracy, reproducibility, and versatility.
The RNA of a living cell, regardless of its origin from an animal, plant, human, bacteria, or virus, is a valuable source of information regarding genetic material. As such, it is a crucial component of gene expression studies. The RNA lysis buffer is known to facilitate the lysis of the cell wall/membrane, whereas the utilization of organic solvents, such as phenol-chloroform, is commonly employed to effectuate the separation of RNA via centrifugation. The utilization of Phenol: Chloroform: Isoamyl alcohol in conjunction with centrifugation results in the formation of three distinct layers. These layers consist of the lower organic layer, the middle layer containing DNA and protein, and the upper aqueous layer containing RNA. The upper aqueous phase is carefully collected and subsequently subjected to precipitation, washing, and dissolution in RNase-free water.
RNA extraction plays an important role in cancer genetic research. It involves mutation analysis, comparative genomic hybridization, and microsatellite analysis. The rising incidence of cancer globally is resulting in the need for advanced RNA extraction kits, which in turn is expected to drive the market in the upcoming years.
Overall, the increasing adoption of the latest technologies such as mutation analysis and comparative genomic hybridization, the prevalence of cancer and the need for advanced genomic techniques, this factors will boost the market in the future.
Competitive Landscape
The viral RNA extraction kit market’s major companies are concentrating on diversifying their product offerings to boost their market share and establish a presence in developing nations. Pricing strategies, market strategies, technology improvements, regulatory compliance, and acquisition and distribution agreements with other firms to extend their company are the main tactics used by manufacturers to acquire a competitive advantage in the market.
For instance:
- In September 2022, HiMedia launched Monkeypox RT-PCR and viral RNA extraction kits for the detection of Monkeypox.
Key Segments Covered in Global Viral RNA Extraction Kit Market Industry Research
By Sample Type:
- Nasal Washes and Swab
- Sputum
- Saliva
- Fecal & Stool
- Urine
- Blood
- Tissues
- Others
By Applications:
- Disease Diagnosis
- Drug Discovery
- Cancer Research
- cDNA Library
- Others
By End User:
- Hospitals
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Clinical Research Organizations
- Diagnostic Laboratories
- Forensic Labs
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa (MEA)
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
